EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Revenue

In the year 2023, EyePoint Pharmaceuticals had annual revenue of $46.02M with 11.14% growth. Revenue in the quarter ending December 31, 2023 was $14.03M with 33.18% year-over-year growth.

• Revenue (ttm): $46.02M
• Revenue Growth: +11.14%
• P/S Ratio: 21.59
• Revenue / Employee: $380,314
• Employees: 121
• Market Cap: 1.05B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	46.02M	4.61M	11.14%
Dec 31, 2022	41.40M	4.47M	12.09%
Dec 31, 2021	36.94M	2.50M	7.27%
Dec 31, 2020	34.44M	14.07M	69.10%
Dec 31, 2019	20.37M	17.40M	587.77%
Jun 30, 2018	2.96M	-4.58M	-60.72%
Jun 30, 2017	7.54M	5.92M	365.37%
Jun 30, 2016	1.62M	-24.95M	-93.90%
Jun 30, 2015	26.57M	23.09M	664.90%
Jun 30, 2014	3.47M	1.33M	62.06%
Jun 30, 2013	2.14M	-1.38M	-39.22%
Jun 30, 2012	3.53M	-1.44M	-28.98%
Jun 30, 2011	4.97M	-18.09M	-78.46%
Jun 30, 2010	23.05M	10.89M	89.55%
Jun 30, 2009	12.16M	8.69M	249.88%
Jun 30, 2008	3.48M	1.69M	94.73%
Jun 30, 2007	1.79M	749.00K	72.30%
Jun 30, 2006	1.04M	909.64K	719.88%
Jun 30, 2005	126.36K	-171.35K	-57.56%
Jun 30, 2004	297.71K	211.38K	244.87%
Jun 30, 2003	86.33K	-628.62K	-87.93%
Jun 30, 2002	714.95K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.